NCT06200857

Brief Summary

Sigmoid diverticulitis (SD) is a common pathology characterized by inflammation/infection of a diverticulum in the sigmoid colon. Surgical treatment of DS is indicated urgently, either because of a serious complication or because of therapeutic failure. Prophylactic surgical treatment of \"cold\" DS is indicated in symptomatic forms (smoldering diverticulitis, frequent recurrences impacting quality of life, symptomatic fistula, and stenosis). It is also indicated for asymptomatic forms in selected patients, to avoid recurrence and/or the occurrence of a DS complication. In France, some 12,000 prophylactic colectomies for DS are performed every year. The mortality rate for this operation during the hospital stay (which does not account for 30-day mortality) is 7 per thousand in France. Morbidity is fairly high, at around 25%, with almost 10% of severe complications. At a distance, the definitive stoma rate is around 6% of patients, and recurrences have been described in up to 10% of cases. Numerous clinical determinants linked to the patient and the pathology have been identified as potential risk factors for morbidity and mortality (advanced age, undernutrition, emergency surgery, neurological history, minimally invasive approach, etc.). Among non-clinical determinants, socio-economic and territorial deprivation is thought to have an impact on postoperative morbidity and mortality for a very large number of pathologies, including cardiovascular disease, cancer, and obesity. Thus, patients from the most disadvantaged backgrounds would have a significantly higher risk of postoperative mortality and morbidity. To our knowledge, however, few data are available on the possible impact of socio-economic deprivation and geographical isolation on the operative outcome of colorectal surgery. This French multicenter study aims to assess the impact of socio-economic and territorial inequalities on the surgical management of sigmoid diverticulitis; with the primary objective being the prevalence of postoperative complications and the secondary objectives being the prevalence of recourse to emergency surgery, minimally invasive surgery, definitive stoma and post-operative recurrence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

December 20, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
Last Updated

January 11, 2024

Status Verified

January 1, 2024

Enrollment Period

1.7 years

First QC Date

December 20, 2023

Last Update Submit

January 9, 2024

Conditions

Keywords

sigmoid diverticulitis _ surgery _ socio-economic inequalities

Outcome Measures

Primary Outcomes (2)

  • 90-day morbidity

    From enrollment to the end of treatment at 90 days

  • 90-day mortality

    From enrollment to the end of treatment at 90 days

Secondary Outcomes (4)

  • - Prevalence of emergency versus prophylactic surgery and type of surgical procedure.

    "From enrollment to the end of treatment at 90 days

  • Prevalence of minimally invasive surgery (laparoscopy, robot) versus laparotomy surgery

    "From enrollment to the end of treatment at 90 days

  • - Prevalence of definitive stoma

    "From enrollment to the end of treatment at 90 days

  • Prevalence of postoperative recurrence

    "From enrollment to the end of treatment at 90 days

Study Arms (1)

association francaise de chirurgie AFC working group

cohort description included all patients aged over 18, undergoing emergency or elective surgery for sigmoid diverticulitis between 2010 and 2019 and with a follow-up of at least 3 months to determine morbi-mortality on the 90th postoperative day. minor patient, those with a final colorectal cancer and those operated on for right colonic diverticulitis were excluded with a follow-up of at least 3 months to determine morbi-mortality on the 90th postoperative day. Non-inclusion criteria for research subjects : * Minor patient * Surgical finding of colorectal cancer The patient operated on for diverticulitis of the right colon

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Patients aged over 18, operated on between 2010 and 2019, for sigmoid diverticulitis * Patients aged 18 and over * Patients undergoing emergency or elective surgery for sigmoid diverticulitis The patient was operated on between January 1, 2010, and December 31, 2019, with a follow-up of at least 3 months to determine morbi-mortality on the 90th postoperative day.

You may qualify if:

  • \- Patients aged over 18, operated on between 2010 and 2019, for sigmoid diverticulitis
  • Patients aged 18 and over
  • Patients undergoing emergency or elective surgery for sigmoid diverticulitis The patient was operated on between January 1, 2010, and December 31, 2019, with a follow-up of at least 3 months to determine morbi-mortality on the 90th postoperative day.

You may not qualify if:

  • \- Minor patient
  • Surgical finding of colorectal cancer The patient operated on for diverticulitis of the right colon
  • Patients with a history of chronic inflammatory bowel disease (Crohn\'s disease, hemorrhagic rectocolitis) and/or hereditary diseases predisposing to colorectal cancer (Lynch syndrome, familial polyposis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CAEN University Hospital

Caen, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 11, 2024

Study Start

January 1, 2020

Primary Completion

September 30, 2021

Study Completion

September 30, 2022

Last Updated

January 11, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations